| Literature DB >> 31932478 |
Eric C Tom1,2, Insha Mushtaq1,3, Bhopal C Mohapatra1,4, Haitao Luan1, Aaqib M Bhat1,4, Neha Zutshi1,3, Sukanya Chakraborty1,4, Namista Islam1,4, Priyanka Arya1,4, Timothy A Bielecki1, Fany M Iseka1,4, Sohinee Bhattacharyya1,3, Luke R Cypher1, Benjamin T Goetz1, Simarjeet K Negi4, Matthew D Storck1, Sandeep Rana1, Angelika Barnekow5, Pankaj K Singh1,2,3,4,6, Guoguang Ying7, Chittibabu Guda4,6, Amarnath Natarajan1,6, Vimla Band8,4,6, Hamid Band8,2,3,4,6.
Abstract
Epidermal growth factor receptor (EGFR) is a prototype receptor tyrosine kinase and an oncoprotein in many solid tumors. Cell surface display of EGFR is essential for cellular responses to its ligands. While postactivation endocytic trafficking of EGFR has been well elucidated, little is known about mechanisms of basal/preactivation surface display of EGFR. Here, we identify a novel role of the endocytic regulator EHD1 and a potential EHD1 partner, RUSC2, in cell surface display of EGFR. EHD1 and RUSC2 colocalize with EGFR in vesicular/tubular structures and at the Golgi compartment. Inducible EHD1 knockdown reduced the cell surface EGFR expression with accumulation at the Golgi compartment, a phenotype rescued by exogenous EHD1. RUSC2 knockdown phenocopied the EHD1 depletion effects. EHD1 or RUSC2 depletion impaired the EGF-induced cell proliferation, demonstrating that the novel, EHD1- and RUSC2-dependent transport of unstimulated EGFR from the Golgi compartment to the cell surface that we describe is functionally important, with implications for physiologic and oncogenic roles of EGFR and targeted cancer therapies.Entities:
Keywords: EGFR; EHD1; cell proliferation; endocytic trafficking
Year: 2020 PMID: 31932478 PMCID: PMC7076251 DOI: 10.1128/MCB.00434-19
Source DB: PubMed Journal: Mol Cell Biol ISSN: 0270-7306 Impact factor: 4.272